North America's legal marijuana market is expected to soar 145%, from $10 billion in 2017 to $24.5 billion by 2021. With such tremendous profit potential, we're bring you the best marijuana stock to buy this year to help you profit from this booming industry.
While there are several marijuana stocks poised to gain from cannabis' gradual legalization, we've found a company that's generating staggering profits from the most robust sector of the current marijuana industry - medical marijuana.
You see, while only a nine U.S. states have legalized marijuana for recreational use, 29 states and the District of Columbia have approved medical marijuana sales and use.
In fact, the domestic medical cannabis market here is expected to grow from $125 million this year to $776 million in 2027 - a gain of 520%.
Let's take a closer look at the drivers behind medical marijuana's growth and the one company that's positioned to reap huge profits from the industry...
The Medical Marijuana Market Is Driving a Pharmaceutical Revolution
The United States isn't the only country moving toward legalizing medical marijuana. In fact, it's a global movement.
In 2017, Germany legalized selling marijuana for medical use. Israel not only legalized medical cannabis use but is home to several companies that develop marijuana pharmaceuticals.
In South America, medical marijuana is permitted in Brazil, Peru, Argentina, and Uruguay.
Pot Stock Profits: A historic event is unfolding in California's marijuana markets, and the wealth expected to flow into this industry is record-breaking. Learn how to cash in here...
Medical marijuana's wide acceptance has fostered a burgeoning pharmaceutical industry that develops cannabis-based treatments for everything from chronic pain to serious neurological diseases and disorders.
To help you to tap into this lucrative market, we're going to show you one of our favorite marijuana stocks to buy right now.
Our top marijuana stock comes from the fast-growing sector of the pharmaceutical industry - it's a company on the verge of some tremendous medical breakthroughs and is looking at share gains of more than 70% over the next 12 months.
Here's our pick...
[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]
GW Pharmaceuticals Plc. Is the Best Marijuana Stock to Buy in 2018
Founded in 1998, GW Pharmaceuticals Plc. (Nasdaq ADR: GWPH) is a global leader in the development of plant-based cannabinoid therapeutics.
GW's greatest strength is the wide range of drugs it's developing using cannabinoids.
The company's main drug, Sativex, has the potential to treat patients with pain from cancer as well as those with a condition known as MS spasticity, which results in muscle spasms and stiffness associated with the disease multiple sclerosis.
GW is also developing Epidiolex, a drug that can treat epilepsy in children while avoiding the cognitive effects of THC but not its calming physical benefits.
Epidiolex has the potential to treat an estimated 95,000 cases in the United States and some 150,000 more in Europe, including children with Dravet syndrome, a rare form of infant epilepsy.
GW Pharmaceuticals has teamed up with some heavy hitters in the pharmaceutical industry in an effort to develop these treatments.
In fact, the company has partnered with some of the worlds' largest publicly traded drug firms and stands to gain more than $300 million in revenue from those alliances alone.
The company currently has a $2.9 billion market cap, so this isn't some fly-by-night penny stock.
Shares of GW currently trade at $116.31. However, GW's price could soar if Epidiolex receives approval from the FDA this June. Analysts believe that FDA approval could send GW to $208 over the next year - a gain of 74.78%.
The profits on the table from this marijuana stock are incredible. However, there's a new market for cannabis opening up that could provide unprecedented gains...
Historic Legislation to Create an Unbelievable Moneymaking Opportunity
Marijuana market expert Michael Robinson recently held a crucial summit to help ordinary folks make millions from California's ongoing cannabis legalization.
We've already seen people collect massive gains from previous legalization announcements, but with the $20 billion in new wealth projected to flood the industry in California alone, this event is about to blow the doors off of anything we've seen so far.
Michael has narrowed down the pool to three of the best, most lucrative, and fastest-growing California pot stocks - tiny players that could turn a small investment into a six-figure payday.
But that's only possible if you go here to learn more now... before the money starts pouring in.
Follow Money Morning on Twitter @moneymorning, Facebook, and LinkedIn.